Outset Medical Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018
Revenue	130.38	115.38	102.6	49.94	15.08	2.01
Revenue Growth (YoY)	13.00%	12.45%	105.47%	231.18%	651.27%	-
Cost of Revenue	101.38	97.54	94.99	62.97	32.88	8.12
Gross Profit	29	17.83	7.61	-13.04	-17.8	-6.12
Selling, General & Admin	141.46	130	101.39	75.58	29.18	17.53
Research & Development	57.31	48.86	36.74	28.85	23.33	22.92
Operating Expenses	198.77	178.85	138.13	104.43	52.51	40.45
Operating Income	-169.77	-161.02	-130.52	-117.47	-70.31	-46.56
Interest Expense / Income	12.68	3.57	1.72	2.89	4.26	4.64
Other Expense / Income	-10.17	-1.92	-0.5	-41.03	10.88	-1.45
Pretax Income	-172.27	-162.66	-131.74	-79.32	-85.44	-49.76
Income Tax	0.52	0.3	0.2	0	0.02	0.03
Net Income	-172.8	-162.96	-131.94	-79.32	-85.46	-49.78
Preferred Dividends	0	0	0	0	0	23.3
Net Income Common	-172.8	-162.96	-131.94	-79.32	-85.46	-73.08
Shares Outstanding (Basic)	50	48	46	16	1	1
Shares Outstanding (Diluted)	50	48	46	16	1	1
Shares Change	2.96%	5.64%	178.70%	1806.53%	18.34%	-
EPS (Basic)	-3.48	-3.38	-2.89	-4.85	-99.58	-100.75
EPS (Diluted)	-3.48	-3.38	-2.89	-4.85	-99.58	-100.75
Free Cash Flow	-134.81	-154.05	-133.37	-108.09	-73.59	-48.21
Free Cash Flow Per Share	-2.72	-3.20	-2.93	-6.61	-85.76	-66.49
Gross Margin	22.24%	15.46%	7.42%	-26.11%	-118.07%	-304.68%
Operating Margin	-130.22%	-139.56%	-127.21%	-235.24%	-466.29%	-2320.03%
Profit Margin	-132.54%	-141.24%	-128.59%	-158.85%	-566.79%	-3641.26%
Free Cash Flow Margin	-103.40%	-133.52%	-129.99%	-216.47%	-488.03%	-2401.99%
EBITDA	-152.52	-152.81	-123.84	-72.68	-79.25	-43.62
EBITDA Margin	-116.98%	-132.45%	-120.70%	-145.55%	-525.59%	-2173.49%
Depreciation & Amortization	7.08	6.28	6.18	3.76	1.94	1.49
EBIT	-159.6	-159.1	-130.02	-76.43	-81.18	-45.12
EBIT Margin	-122.41%	-137.89%	-126.72%	-153.06%	-538.43%	-2247.93%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).